Y
Yi Ning
Researcher at Johns Hopkins University School of Medicine
Publications - 101
Citations - 7686
Yi Ning is an academic researcher from Johns Hopkins University School of Medicine. The author has contributed to research in topics: Myeloid leukemia & Cytogenetics. The author has an hindex of 32, co-authored 91 publications receiving 7311 citations. Previous affiliations of Yi Ning include George Washington University & University of Maryland Marlene and Stewart Greenebaum Cancer Center.
Papers
More filters
Journal ArticleDOI
Multicolor Spectral Karyotyping of Human Chromosomes
Evelin Schröck,S du Manoir,T Veldman,B Schoell,Johannes Wienberg,Malcolm A. Ferguson-Smith,Yi Ning,David H. Ledbetter,Irit Bar-Am,D. Soenksen,Yuval Garini,Thomas Ried +11 more
TL;DR: Whole-genome scanning by spectral karyotyping allowed instantaneous visualization of defined emission spectra for each human chromosome after fluorescence in situ hybridization, and all human chromosomes were simultaneously identified.
Journal ArticleDOI
Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen.
TL;DR: Three cDNAs, referred to as senescent cell-derived inhibitors (sdi), that exhibit DNA synthesis-inhibitory activity when introduced into young cycling cells, were successfully identified and expression of one of them, sdi1, increased 10- to 20-fold in senescent compared with young cells and the increase in RNA closely paralleled the onset of the senescent phenotype and loss of cell proliferation.
Journal ArticleDOI
Autosomal XX Sex Reversal Caused by Duplication of SOX9
TL;DR: It is suggested that extra dose of SOX9 is sufficient to initiate testis differentiation in the absence of SRY, and other SRY-negative XX sex-reversed individuals deserve thorough investigation of SoX9 gene.
Journal ArticleDOI
Pretreatment cytogenetics add to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia: results from Cancer and Leukemia Group B 8461.
Sherif S. Farag,Kellie J. Archer,Krzysztof Mrózek,Amy S. Ruppert,Andrew J. Carroll,James W. Vardiman,Mark J. Pettenati,Maria R. Baer,Mazin B. Qumsiyeh,Prasad Koduru,Yi Ning,Robert J. Mayer,Richard Stone,Richard A. Larson,Clara D. Bloomfield +14 more
TL;DR: Pretreatment cytogenetics adds to other prognostic factors in older AML patients, and patients with complex > or = 5 appear to benefit minimally from current treatment and are better suited for investigational therapy or supportive care.
Journal ArticleDOI
A complete set of human telomeric probes and their clinical application
Yi Ning,Anna V. Roschke,Ann C.M. Smith,Ann C.M. Smith,Michelle Macha,Michelle Macha,Kathrin S. Precht,Kathrin S. Precht,Harold Riethman,Harold Riethman,David H. Ledbetter,David H. Ledbetter,J Flint,J Flint,Sharon W. Horsley,Sharon W. Horsley,Regina Regan,Regina Regan,Lyndal Kearney,Lyndal Kearney,Samantha J. L. Knight,Samantha J. L. Knight,Kirsti Kvaløy,Kirsti Kvaløy,William Brown,William Brown +25 more
TL;DR: In isolation and characterization of a complete set of specific FISH probes representing each human telomere, this provides a 10-fold improvement in deletion detection sensitivity compared with high-resolution cytogenetics.